Sumatriptan Succinate Tablets

Closed Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
SPE2D223R0003
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

Notice text

4 versions

Update #4 · Latest ·

Amendment 0003 issued February 03,2023 to extend the closing date from February 03, 2023 3:00 PM to February 17,  2023 3:00 PM EST. 

Amendment 0002 issued January 04,2023 to extend the closing date from January 20, 2023 3:00 PM to February 03,  2023 3:00 PM EST. 

Amemdment 0001 issued December 15, 2022 to incorporate statement, DOD Class Deviation 2023-O0001, Verification of Eligibility of Small Business Joint Ventures, into solicitation.  

SPE2D2-23-R-0003 SUMATRIPTAN SUCCINATE TABLET SOLICITATION 

Update #3 ·

Amendment 0002 issued January 04,2023 to extend the closing date from January 20, 2023 3:00 PM to February 03,  2023 3:00 PM. 

Amemdment 0001 issued December 15, 2022 to incorporate statement, DOD Class Deviation 2023-O0001, Verification of Eligibility of Small Business Joint Ventures, into solicitation.  

SPE2D2-23-R-0003 SUMATRIPTAN SUCCINATE TABLET SOLICITATION 

Update #2 ·

Amemdment 0001 issued December 15, 2022 to incorporate statement, DOD Class Deviation 2023-O0001, Verification of Eligibility of Small Business Joint Ventures, into solicitation.  

SPE2D2-23-R-0003 SUMATRIPTAN SUCCINATE TABLET SOLICITATION 

Update #1 ·

SPE2D2-23-R-0003 SUMATRIPTAN SUCCINATE TABLET SOLICITATION 

Files

Notice history

Notice Type Posted
Sumatriptan Succinate Tablets Award Award Notice
This notice Latest solicitation Solicitation
Sumatriptan Succinate Tablets Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors